Kiira Tietjen - New Chapter TMS, Psychiatric Nurse Practitioner, Spokane, WA, 99202, (509) 268-4022, We offer TMS treatment for depression and anxiety that has not responded to medication. New ...

As access to NeuroStar TMS grows, more families will have the opportunity to pursue effective treatments for depression, addressing a critical need in the U.S. mental health landscape.

Neuronetics announced that Evernorth will offer coverage for its NeuroStar Transcranial Magnetic Stimulation (TMS) therapy to patients aged 15 and older who have major depressive disorder.

TMS Device NeuroStar Cleared for Anxious Depression Brian Park, PharmD | July 19, 2022 ...

The Food and Drug Administration (FDA) has cleared NeuroStar ® Advanced Therapy for use as an adjunct in the treatment of major depressive disorder (MDD) in patients 15 to 21 years of age ...

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...

NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.9 million treatments delivered.

NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults, with more than 6.9 million treatments delivered, and is backed by the largest clinical data set of any TMS treatment ...

NeuroStar also participated in the PULSES Course, a foundational training session for TMS providers, and exhibited at booth #303. Additionally, Neuronetics provided an update on Greenbrook Mental ...